Clinical Trial

Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated March 24, 2026 completion). Its status may not reflect the trial's current state.
Summary
The trial uses a randomized, open-label, single-dose administration per period, and a 2 x 2 crossover design where subjects receive both treatments sequentially with a washout.
Trial Details
NCT Number NCT07337174
Lead Sponsor Huons Co., Ltd.
Conditions Obesity
Enrollment 40 participants
Start Date 2026-01-25
Primary Completion 2026-03-24 (estimated)
Study Completion 2026-03-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-13